Directorio de personas
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grado: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publicaciones

  • MATIASGUIU, X; PONS, C; MUNOZ, J; PRAT, J

    BIOTIN-CONTaINING INTRaNUCLEaR INCLUSIONS IN TUMOR-CELLS - POSSIBLE CaUSE FOR MISINTERPRETING NUCLEaR aNTIGEN IMMUNOSTaINING

    AMERICAN JOURNAL OF CLINICAL PATHOLOGY 102 706-707. .

  • KOMMINOTH, P; KUNZ, E; HIORT, O; SCHRODER, S; MATIASGUIU, X; CHRISTIANSEN, G; ROTH, J; HEITZ, PU

    DETECTION OF RET PROTOONCOGENE POINT MUTaTIONS IN PaRaFFIN-EMBEDDED PHEOCHROMOCYTOMa SPECIMENS BY NONRaDIOaCTIVE SINGLE-STRaND CONFORMaTION POLYMORPHISM aNaLYSIS aND DIRECT SEQUENCING

    AMERICAN JOURNAL OF PATHOLOGY 145 922-929. .

  • PRAT, J; OLIVA, E; LERMA, E; VAQUERO, M; MATIASGUIU, X

    UTERINE PaPILLaRY SEROUS aDENOCaRCINOMa - a 10-CaSE STUDY OF P53 aND C-ERBB-2 EXPRESSION aND DNa CONTENT

    CANCER 74 1778-1783. .

    [doi:10.1002/1097-0142(19940915)74:6<1778::AID-CNCR2820740621>3.0.CO;2-5]

  • MATIASGUIU, X; CAIXAS, A; COSTA, I; CABEZAS, R; PRAT, J

    COMPOUND MEDULLaRY-PaPILLaRY CaRCINOMa OF THE THYROID - TRUE MIXED TUMOR

    Histopathology 25 183-185. .

    [doi:10.1111/j.1365-2559.1994.tb01578.x]

  • MATIASGUIU, X; CUATRECASAS, M; MUSULEN, E; PRAT, J

    P53 EXPRESSION IN aNaPLaSTIC CaRCINOMaS aRISING FROM THYROID PaPILLaRY CaRCINOMaS

    JOURNAL OF CLINICAL PATHOLOGY 47 337-339. .

    [doi:10.1136/jcp.47.4.337]

  • KOMMINOTH, P; ROTH, J; SAREMASLANI, P; MATIASGUIU, X; WOLFE, HJ; HEITZ, PU

    POLYSIaLIC aCID OF THE NEURaL CELL-aDHESION MOLECULE IN THE HUMaN THYROID - a MaRKER FOR MEDULLaRY-THYROID CaRCINOMa aND PRIMaRY C-CELL HYPERPLaSIa - aN IMMUNOHISTOCHEMICaL STUDY ON 79 THYROID LESIONS

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY 18 399-411. .

    [doi:10.1097/00000478-199404000-00008]

  • MATIASGUIU, X; PRAT, J; YOUNG, RH; CAPEN, CC; ROSOL, TJ; DELELLIS, RA; SCULLY, RE

    HUMaN PaRaTHYROID-HORMONE RELaTED PROTEIN IN OVaRIaN SMaLL-CELL CaRCINOMa - aN IMMUNOHISTOCHEMICaL STUDY

    CANCER 73 1878-1881. .

    [doi:10.1002/1097-0142(19940401)73:7<1878::AID-CNCR2820730717>3.0.CO;2-D]

  • PRAT, J; CUATRECASAS, M; MATIASGUIU, X; VILLANUEVA, A; CAPELLA, G

    K-RaS MUTaTIONS IN OVaRIaN MUCINOUS TUMORS

    LABORATORY INVESTIGATION 70 94-94. .

  • MATIASGUIU, X; COLOMER, A; MARTINEZMAS, JV; PRAT, J; CARCIAAMEJEIRAS, A

    ESTROGEN aND PROGESTERONE RECEPTORS IN MEDULLaRY-THYROID CaRCINOMa - a LIGaND-BINDING aND IMMUNOHISTOCHEMICaL STUDY

    LABORATORY INVESTIGATION 70 54-54. .

  • MATIASGUIU, X; KOMMINOTH, P; PRAT, J

    ABSENCE OF EPSTEIN-BaRR-VIRUS DNa IN LYMPHOEPITHELIOMa-LIKE CaRCINOMa OF THE UTERINE CERVIX

    AMERICAN JOURNAL OF CLINICAL PATHOLOGY 101 117-117. .

  • ESPINOS, JJ; GARCIAPATOS, V; Guiu, XM; DELGADO, E

    EaRLY SKIN METaSTaSIS OF ENDOMETRIaL aDENOCaRCINOMa - CaSE-REPORT aND REVIEW OF THE LITERaTURE

    Cutis 52 109-111. .

  • ALEJO, M; MACEDO, I; MATIASGUIU, X; PRAT, J

    ADENOCaRCINOMa IN-SITU OF THE UTERINE CERVIX - CLINICOPaTHOLOGICaL STUDY OF 9 CaSES WITH DETECTION OF HUMaN PaPILLOMaVIRUS DNa BY IN-SITU HYBRIDIZaTION aND POLYMERaSE CHaIN-REaCTION

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 12 219-223. .

    [doi:10.1097/00004347-199307000-00003]

Proyectos

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU